In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.

COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.

Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Due to changes in the collection and availability of data on COVID-19 this page will no longer be updated. The webpage will no longer be available as of 11 May 2023. On-going, reliable sources of data for COVID-19 are available via the COVID-19 dashboard, Office for National Statistics, and the UKHSA

This page provides a weekly summary of data on deaths related to COVID-19 published by NHS England and the Office for National Statistics. More frequent reporting on COVID-19 deaths is now available here, alongside data on cases, hospitalisations, and vaccinations.

This update contains data on deaths related to COVID-19 from:

• NHS England COVID-19 Daily Deaths - last updated on 28 June 2022 with data up to and including 27 June 2022.
• ONS weekly deaths by Local Authority - last updated on 16 August 2022 with data up to and including 05 August 2022.

Summary notes about each these sources are provided at the end of this document.

Note on interpreting deaths data: statistics from the available sources differ in definition, timing and completeness. It is important to understand these differences when interpreting the data or comparing between sources.

Weekly Key Points

• An additional 24 deaths in London hospitals of patients who had tested positive for COVID-19 and an additional 5 where COVID-19 was mentioned on the death certificate were announced in the week ending 27 June 2022. This compares with 40 and 3 for the previous week.
• A total of 306 deaths in hospitals of patients who had tested positive for COVID-19 and 27 where COVID-19 was mentioned on the death certificate were announced for England as whole. This compares with 301 and 26 for the previous week.
• The total number of COVID-19 deaths reported in London hospitals of patients who had tested positive for COVID-19 is now 19,102. The total number of deaths in London hospitals where COVID-19 was mentioned on the death certificate is now 1,590.
• This compares to figures of 119,237 and 8,197 for English hospitals as a whole.
• Due to the delay between death occurrence and reporting, the estimated number of deaths to this point will be revised upwards over coming days
• These figures do not include deaths that occurred outside of hospitals. Data from ONS has indicated that the majority (79%) of COVID-19 deaths in London have taken place in hospitals.

Recently announced deaths in Hospitals

https://cdn.datapress.cloud/london/img/dataset/2406874d-a960-49d0-bbd5-3ea57c4a9b85/2025-06-09T20%3A54%3A56/e58736bd8800e0fe2b32fc2eb79e37da.webp" width="3840" alt="Embedded Image" />

21 June 22 June 23 June 24 June 25 June 26 June 27 June London No positive test 0 0 1 4 0 0 0 London Positive test 3 7 2 10 0 0 2 Rest of England No positive test 2 6 4 4 0 0 6 Rest of England Positive test 47 49 41 58 6 0 81 https://cdn.datapress.cloud/london/img/dataset/2406874d-a960-49d0-bbd5-3ea57c4a9b85/2025-06-09T20%3A54%3A57/527d64c1e783180ed460de85c1781ec5.webp" width="3840" alt="Embedded Image" />

16 May 23 May 30 May 06 June 13 June 20 June 27 June London No positive test 14 3 4 0 4 3 5 London Positive test 45 34 55 20 62 40 24 Rest of England No positive test 41 58 33 23 47 23 22 Rest of England Positive test 456 375 266 218 254 261 282 Deaths by date of occurrence

https://cdn.datapress.cloud/london/img/dataset/2406874d-a960-49d0-bbd5-3ea57c4a9b85/2025-06-09T20%3A54%3A57/c5d895e060bb2af8255978c92f2d5416.webp" width="3840" alt="Embedded Image" />

https://cdn.datapress.cloud/london/img/dataset/2406874d-a960-49d0-bbd5-3ea57c4a9b85/2025-06-09T20%3A54%3A58/5f9687a97d398aae070ec876c0b18b35.webp" width="3840" alt="Embedded Image" />

https://cdn.datapress.cloud/london/img/dataset/2406874d-a960-49d0-bbd5-3ea57c4a9b85/2025-06-09T20%3A54%3A58/4691f3cf7b2cd77786a48c3414bfa910.webp" width="3840" alt="Embedded Image" />

21 June 22 June 23 June 24 June 25 June 26 June 27 June London 20,683 20,686 20,690 20,691 20,692 20,692 20,692 Rest of England 106,604 106,635 106,679 106,697 106,713 106,733 106,742 Interpreting the data

The data published by NHS England are incomplete due to:

• delays in the occur

In early-February, 2020, the first cases of the coronavirus (COVID-19) were reported in the United Kingdom (UK). The number of cases in the UK has since risen to 24,243,393, with 1,062 new cases reported on January 13, 2023. The highest daily figure since the beginning of the pandemic was on January 6, 2022 at 275,646 cases.

COVID deaths in the UK COVID-19 has so far been responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK has one of the highest death toll from COVID-19 in Europe. As of January 13, the incidence of deaths in the UK is 298 per 100,000 population.

Regional breakdown The South East has the highest amount of cases in the country with 3,123,050 confirmed cases as of January 11. London and the North West have 2,912,859 and 2,580,090 cases respectively.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

On March 4, 2020, the first death as a result of coronavirus (COVID-19) was recorded in the United Kingdom (UK). The number of deaths in the UK has increased significantly since then. As of January 13, 2023, the number of confirmed deaths due to coronavirus in the UK amounted to 202,157. On January 21, 2021, 1,370 deaths were recorded, which was the highest total in single day in the UK since the outbreak began.

Number of deaths among highest in Europe
The UK has had the highest number of deaths from coronavirus in western Europe. In terms of rate of coronavirus deaths, the UK has recorded 297.8 deaths per 100,000 population.

Cases in the UK The number of confirmed cases of coronavirus in the UK was 24,243,393 as of January 13, 2023. The South East has the highest number of first-episode confirmed cases of the virus in the UK with 3,123,050 cases, while London and the North West have 2,912,859 and 2,580,090 confirmed cases respectively. As of January 16, the UK has had 50 new cases per 100,000 in the last seven days.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This mapping tool enables you to see how COVID-19 deaths in your area may relate to factors in the local population, which research has shown are associated with COVID-19 mortality. It maps COVID-19 deaths rates for small areas of London (known as MSOAs) and enables you to compare these to a number of other factors including the Index of Multiple Deprivation, the age and ethnicity of the local population, extent of pre-existing health conditions in the local population, and occupational data. Research has shown that the mortality risk from COVID-19 is higher for people of older age groups, for men, for people with pre-existing health conditions, and for people from BAME backgrounds. London boroughs had some of the highest mortality rates from COVID-19 based on data to April 17th 2020, based on data from the Office for National Statistics (ONS). Analysis from the ONS has also shown how mortality is also related to socio-economic issues such as occupations classified ‘at risk’ and area deprivation. There is much about COVID-19-related mortality that is still not fully understood, including the intersection between the different factors e.g. relationship between BAME groups and occupation. On their own, none of these individual factors correlate strongly with deaths for these small areas. This is most likely because the most relevant factors will vary from area to area. In some cases it may relate to the age of the population, in others it may relate to the prevalence of underlying health conditions, area deprivation or the proportion of the population working in ‘at risk occupations’, and in some cases a combination of these or none of them. Further descriptive analysis of the factors in this tool can be found here: https://data.london.gov.uk/dataset/covid-19--socio-economic-risk-factors-briefing

This mapping tool enables you to see how COVID-19 deaths in your area may relate to factors in the local population, which research has shown are associated with COVID-19 mortality. It maps COVID-19 deaths rates for small areas of London (known as MSOAs) and enables you to compare these to a number of other factors including the Index of Multiple Deprivation, the age and ethnicity of the local population, extent of pre-existing health conditions in the local population, and occupational data. Research has shown that the mortality risk from COVID-19 is higher for people of older age groups, for men, for people with pre-existing health conditions, and for people from BAME backgrounds. London boroughs had some of the highest mortality rates from COVID-19 based on data to April 17th 2020, based on data from the Office for National Statistics (ONS). Analysis from the ONS has also shown how mortality is also related to socio-economic issues such as occupations classified ‘at risk’ and area deprivation. There is much about COVID-19-related mortality that is still not fully understood, including the intersection between the different factors e.g. relationship between BAME groups and occupation. On their own, none of these individual factors correlate strongly with deaths for these small areas. This is most likely because the most relevant factors will vary from area to area. In some cases it may relate to the age of the population, in others it may relate to the prevalence of underlying health conditions, area deprivation or the proportion of the population working in ‘at risk occupations’, and in some cases a combination of these or none of them. Further descriptive analysis of the factors in this tool can be found here: https://data.london.gov.uk/dataset/covid-19--socio-economic-risk-factors-briefing

The COVID Symptom Tracker (https://covid.joinzoe.com/) mobile application was designed by doctors and scientists at King's College London, Guys and St Thomas’ Hospitals working in partnership with ZOE Global Ltd – a health science company.

This research is led by Dr Tim Spector, professor of genetic epidemiology at King’s College London and director of TwinsUK a scientific study of 15,000 identical and non-identical twins, which has been running for nearly three decades.

The dataset schema includes:

Demographic Information (Year of Birth, Gender, Height, Weight, Postcode) Health Screening Questions (Activity, Heart Disease, Diabetes, Lung Disease, Smoking Status, Kidney Disease, Chemotherapy, Immunosuppressants, Corticosteroids, Blood Pressure Medications, Previous COVID, COVID Symptoms, Needs Help, Housebound Problems, Help Availability, Mobility Aid) COVID Testing Conducted How You Feel? Symptom Description Location Information (Home, Hospital, Back From Hospital) Treatment Received The data is hosted within the SAIL Databank, a trusted research environment facilitating remote access to health, social care, and administrative data for various national organisations.

The process for requesting access to the data is dependent on your use case. SAIL is currently expediting all requests that feed directly into the response to the COVID-19 national emergency, and therefore requests from NHS or Government institutions, or organisations working alongside such care providers and policymakers to feed intelligence directly back into the national response, are being expedited with a ~48-hour governance turnaround for such applications once made. Please make enquiries using the link at the bottom of the page which will go the SAIL Databank team, or to Chris Orton at c.orton@swansea.ac.uk

SAIL is welcoming requests from other organisations and for longer-term academic study on the dataset, but please note if this is not directly relevant to the emergency research being carried out which directly interfaces with national responding agencies, there may be an access delay whilst priority use cases are serviced.

Please note: the CVST dataset in SAIL has not been updated since 01/11/2023.

This dataset requires additional governance approvals from the data provider before data can be provisioned to a SAIL project.

This is an indicator designed to accompany the Summary Hospital-level Mortality Indicator (SHMI). As of the July 2020 publication, COVID-19 activity has been excluded from the SHMI. The SHMI is not designed for this type of pandemic activity and the statistical modelling used to calculate the SHMI may not be as robust if such activity were included. This indicator shows the number of provider spells which are coded as COVID-19, and therefore excluded from the SHMI, as a percentage of all provider spells in the SHMI (prior to the exclusion). This indicator is being published as an experimental statistic. Experimental statistics are official statistics which are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage. Notes: 1. Please note that there has been a fall in the number of spells for most trusts between this publication and the previous SHMI publication, ranging from 0 per cent to 5 per cent. This is due to COVID-19 impacting on activity from March 2020 onwards and appears to be an accurate reflection of hospital activity rather than a case of missing data. 2. The data for St Helens and Knowsley Teaching Hospitals NHS Trust (trust code RBN) has incomplete information on secondary conditions that the patients suffers from, and this will have affected the calculation of this indicator. Values for this trust should therefore be interpreted with caution. Please note, this issue was not identified until after this publication was initially released on 13th May 2021. Data quality notices were later added to this publication in July 2021. 3. Day cases and regular day attenders are excluded from the SHMI. However, some day cases for University College London Hospitals NHS Foundation Trust (trust code RRV) have been incorrectly classified as ordinary admissions meaning that they have been included in the SHMI. Maidstone and Tunbridge Wells NHS Trust (trust code RWF) has submitted a number of records with a patient classification of ‘day case’ or ‘regular day attender’ and an intended management value of ‘patient to stay in hospital for at least one night’. This mismatch has resulted in the patient classification being updated to ‘ordinary admission’ by the HES data cleaning rules. This may have resulted in the number of ordinary admissions being overstated. The trust has been contacted to clarify what the correct patient classification is for these records. Values for these trusts should therefore be interpreted with caution. 4. There is a shortfall in the number of records for Mid Cheshire Hospitals NHS Foundation Trust (trust code RBT), meaning that values for this trust are based on incomplete data and should therefore be interpreted with caution. 5. We recommend that values for Guy’s and St Thomas’ NHS Foundation Trust (trust code RJ1) are interpreted with caution as there is a possible shortfall in the number of records which is currently under investigation. 6. On 1 April 2021 Western Sussex Hospitals NHS Foundation Trust (trust code RYR) merged with Brighton and Sussex University Hospitals NHS Trust (trust code RXH). The new trust is called University Hospitals Sussex NHS Foundation Trust (trust code RYR). However, as we received notification of this change after data processing for this publication began, separate indicator values have been produced for this publication. The next publication in this series will reflect the updated organisation structure. 7. Further information on data quality can be found in the SHMI background quality report, which can be downloaded from the 'Resources' section of the publication page.

As of January 12, 2023, COVID-19 has been responsible for 202,157 deaths in the UK overall. The North West of England has been the most affected area in terms of deaths at 28,116, followed by the South East of England with 26,221 coronavirus deaths. Furthermore, there have been 22,264 mortalities in London as a result of COVID-19.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

The Centre for Longitudinal Studies (CLS) and the MRC Unit for Lifelong Health and Ageing (LHA) have carried out two online surveys of the participants of five national longitudinal cohort studies which have collected insights into the lives of study participants including their physical and mental health and wellbeing, family and relationships, education, work, and finances during the coronavirus pandemic. The Wave 1 Survey was carried out at the height of lockdown restrictions in May 2020 and focussed mainly on how participants’ lives had changed from just before the outbreak of the pandemic in March 2020 until then. The Wave 2 survey was conducted in September/October 2020 and focussed on the period between the easing of restrictions in June through the summer into the autumn. A third wave of the survey was conducted in early 2021.

In addition, CLS study members who had participated in any of the three COVID-19 Surveys were invited to provide a finger-prick blood sample to be analysed for COVID-19 antibodies. Those who agreed were sent a blood sample collection kit and were asked to post back the sample to a laboratory for analysis. The antibody test results and initial short survey responses are included in a single dataset, the COVID-19 Antibody Testing in the National Child Development Study, 1970 British Cohort Study, Next Steps and Millennium Cohort Study, 2021 (SN 8823).

The CLS studies are:

• Millennium Cohort Study (born 2000-02) both cohort members and parents (MCS)
• Next Steps (born 1989-90) (NS)
• 1970 British Cohort Study (BCS70)
• 1958 National Child Development Study (NCDS).

The LHA study is:

• MRC National Survey of Health and Development, 1946 British birth cohort (NSHD)

The content of the MCS, NS, BCS70 and NCDS COVID-19 studies, including questions, topics and variables can be explored via the CLOSER Discovery website.

The COVID-19 Survey in Five National Longitudinal Cohort Studies: Millennium Cohort Study, Next Steps, 1970 British Cohort Study and 1958 National Child Development Study, 2020-2021 contains the data from waves 1, 2 and 3 for the 4 cohort studies. The data from all four CLS cohorts are included in the same dataset, one for each wave.

The COVID-19 Survey data for the 1946 birth cohort study (NSHD) run by the LHA is held under "https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=8732" style="background-color: rgb(255, 255, 255);">SN 8732 and available under Special Licence access conditions.

Latest edition information
For the fourth edition (June 2022), the following minor corrections have been made to the wave 3 data:

• corrections to a small number of cases where CW3_GROW and CW3_GROWB were incorrectly calculated
• recoded values and reformatted the code list for CW3_COVIDVAC as the original value of 3 was removed from the final version of the survey
  

Introduction

The 2023 mid-year estimate (MYE) is the current official estimate of the population for local authorities in England and Wales. Estimates are produced annually by the Office for National Statistics (ONS) and the 2023 MYE was published on 15 July 2024.

Comparison to previous MYE data

The previous MYE series (for the period 2012-2020) starts with the 2011 census estimate. Each subsequent year’s population is calculated by adding estimates of births, deaths and migration to the previous year’s population. The 2021 MYE represents a break in this series as it uses the 2021 census as its base.

The ONS revised the 2012-2020 MYE series to bring it in line with the 2021 MYE, so that comparisons could be made between between this series and the previous series. The values plotted on the chart are the revised values of the previously published estimates for 2011 to 2022, together with the estimates for 2023.

Key Points

• London’s mid-2023 population was 8.945 million
• London’s population increased by 76,300 persons compared to the previous mid-year value
• Components of change were as follows:
• 105,100 births and 53,500 deaths (natural change of 51,600)
• Net domestic migration was an outflow of 129,200
• Net international migration was an inflow of 154,100

Population Change

London’s 2023 population was 8,945,310. The first chart below shows the 2023 MYE in the context of previous estimates. There is an uptick after a temporary decrease in population which we attribute to the COVID-19 pandemic.

https://cdn.datapress.cloud/london/img/dataset/763802e7-af17-4b77-995d-44c494fb68af/2025-06-09T20%3A56%3A29/666cd938678c5361c953cb608e532416.webp" width="1152" alt="Embedded Image" />

Components of Change

Births, deaths and migration form the components of population change.

The 2023 MYE value for births was 4% lower than that in 2022, and for deaths 3% higher. The consequent value for natural change (births - deaths) was 10% lower than in 2022.

At -129,000, the value for domestic migration (migration within the UK) was nearly 3% higher than the 2022 value, so still significantly lower than the peak net outflow during the COVID-19 pandemic of -186,000. An outflow of domestic migrants from London is normal and this has been the case each year for the last two decades. This flow is partly because many international in-migrants initially settle in London before moving out to other parts of the UK. The second move in this sequence is counted as a domestic migration.

There has been a marked change in immigration since 2021. This can be attributed to the end of free movement for EU nationals, easing of travel restrictions following the COVID 19 pandemic, and the war in Ukraine. At over 150,000, the 2023 MYE value for London’s net international migration was more than 18% higher than 2022, and represents a considerable increase from 78,000 in 2021.

https://cdn.datapress.cloud/london/img/dataset/763802e7-af17-4b77-995d-44c494fb68af/2025-06-09T20%3A56%3A29/cb537d44954e11f7f7b7e2189ae74629.webp" width="1152" alt="Embedded Image" />

Age structure of the population

https://cdn.datapress.cloud/london/img/dataset/763802e7-af17-4b77-995d-44c494fb68af/2025-06-09T20%3A56%3A29/6d4cf55b96888dbc3aacfc1de5c664ec.webp" width="1152" alt="Embedded Image" />

Future Updates

The release of the next mid-year estimates is expected in July 2025.

The full ONS mid-year population estimates release and back series can be found on the ONS website: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates.

For information relating to London’s population see the demography pages of the London Datastore: https://data.london.gov.uk/demography/ or email demography@london.gov.uk.

An in-depth review of the available evidence for population change in London since the start of the coronavirus pandemic has been produced by GLA Demography: https://data.london.gov.uk/dataset/population-change-in-london-during-the-pandemic.

These indicators are designed to accompany the SHMI publication. As of the July 2020 publication, COVID-19 activity has been excluded from the SHMI. The SHMI is not designed for this type of pandemic activity and the statistical modelling used to calculate the SHMI may not be as robust if such activity were included. There has been a fall in the number of spells for some trusts due to COVID-19 impacting on activity from March 2020 onwards and this appears to be an accurate reflection of hospital activity rather than a case of missing data. Contextual indicators on the number of provider spells which are excluded from the SHMI due to them being related to COVID-19 and on the number of provider spells as a percentage of pre-pandemic activity (January 2019 – December 2019) are produced to support the interpretation of the SHMI. These indicators are being published as experimental statistics. Experimental statistics are official statistics which are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage. Notes: 1. Day cases and regular day attenders are excluded from the SHMI. However, some day cases for University College London Hospitals NHS Foundation Trust (trust code RRV) have been incorrectly classified as ordinary admissions meaning that they have been included in the SHMI. Maidstone and Tunbridge Wells NHS Trust (trust code RWF) has submitted a number of records with a patient classification of ‘day case’ or ‘regular day attender’ and an intended management value of ‘patient to stay in hospital for at least one night’. This mismatch has resulted in the patient classification being updated to ‘ordinary admission’ by the Hospital Episode Statistics (HES) data cleaning rules. This may have resulted in the number of ordinary admissions being overstated. The trust has been contacted to clarify what the correct patient classification is for these records. Values for these trusts should therefore be interpreted with caution. 2. In the current period, there is a shortfall in the number of records Royal Free London NHS Foundation Trust (trust code RAL). Values for this trust are based on incomplete data and should therefore be interpreted with caution. 3. On 1st April 2022 Northern Devon Healthcare NHS Trust (trust code RBZ) merged with Royal Devon and Exeter NHS Foundation Trust (trust code RH8). The new trust is called Royal Devon University Healthcare NHS Foundation Trust (trust code RH8). This new organisation structure is reflected from this publication onwards. 4. Further information on data quality can be found in the SHMI background quality report, which can be downloaded from the 'Resources' section of the publication page.

As of October 3, 2023, there were 2,189,008 confirmed cases of coronavirus (COVID-19) in Scotland. The Greater Glasgow and Clyde health board has the highest amount of confirmed cases at 514,117, although this is also the most populated part of Scotland. The Lothian health board has 368,930 confirmed cases which contains Edinburgh, the capital city of Scotland.

Situation in the rest of the UK Across the whole of the UK there have been 24,243,393 confirmed cases of coronavirus as of January 2023. Scotland currently has fewer cases than four regions in England. As of December 2023, the South East has the highest number of confirmed first-episode cases of the virus in the UK with 3,180,101 registered cases, while London and the North West have 2,947,7271 and 2,621,449 confirmed cases, respectively.

COVID deaths in the UK COVID-19 has so far been responsible for 202,157deaths in the UK as of January 13, 2023, and the UK has had the highest death toll from coronavirus in Western Europe. The incidence of deaths in the UK is 297.8 per 100,000 population.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Parameter tuning in the UK case.

Russia had over 23 million COVID-19 cases as of October 22, 2023. Over the past week, that figure increased by nearly 20 thousand. Russia had the 10th-highest number of coronavirus (COVID-19) cases worldwide. Debate about COVID-19 deaths in Russia The number of deaths from the disease was lower than in other countries most affected by the pandemic. Several foreign media sources, including New York Times and Financial Times, published articles suggesting that the official statistics on the COVID-19 death toll in Russia could be lowered. A narrow definition of a death from COVID-19 and a general increase in mortality in Moscow were pointed out while suggesting why actual death figures could be higher than reported. Russian explanation of lower COVID-19 deaths Experts and lawmakers from Russia provided several answers to the accusations. Among them were the fact that Russians timely reported symptoms to doctors, a high number of tests conducted, as well as a higher herd immunity of the population compared to other countries. In a letter to the New York Times, Moscow’s health department head argued that even if all the additional death cases in the Russian capital in April 2020 were categorized as caused by the COVID-19, the city’s mortality rate from the disease would still be lower than in cities like New York or London.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Characteristics of the adult population aged 65+with multimorbidity and active depression in Northwest London during Covid-19 lockdown (Period 1, 23rd Mar 2020 – 21st June 2021) and post Covid-19 lockdown (Period 2, 22nd June 2021 – 19th Sept 2022).

Background: There is insufficient evidence to support clinical decision-making for cancer patients diagnosed with COVID-19 due to the lack of large studies.Methods: We used data from a single large UK Cancer Center to assess the demographic/clinical characteristics of 156 cancer patients with a confirmed COVID-19 diagnosis between 29 February and 12 May 2020. Logistic/Cox proportional hazards models were used to identify which demographic and/or clinical characteristics were associated with COVID-19 severity/death.Results: 128 (82%) presented with mild/moderate COVID-19 and 28 (18%) with a severe case of the disease. An initial cancer diagnosis >24 months before COVID-19 [OR: 1.74 (95% CI: 0.71–4.26)], presenting with fever [6.21 (1.76–21.99)], dyspnea [2.60 (1.00–6.76)], gastro-intestinal symptoms [7.38 (2.71–20.16)], or higher levels of C-reactive protein [9.43 (0.73–121.12)] were linked with greater COVID-19 severity. During a median follow-up of 37 days, 34 patients had died of COVID-19 (22%). Being of Asian ethnicity [3.73 (1.28–10.91)], receiving palliative treatment [5.74 (1.15–28.79)], having an initial cancer diagnosis >24 months before [2.14 (1.04–4.44)], dyspnea [4.94 (1.99–12.25)], and increased CRP levels [10.35 (1.05–52.21)] were positively associated with COVID-19 death. An inverse association was observed with increased levels of albumin [0.04 (0.01–0.04)].Conclusions: A longer-established diagnosis of cancer was associated with increased severity of infection as well as COVID-19 death, possibly reflecting the effects a more advanced malignant disease has on this infection. Asian ethnicity and palliative treatment were also associated with COVID-19 death in cancer patients.